Metabolic changes in hypertrophic cardiomyopathies

Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology

Jolanda van der Velden, Carlo Gabriele Tocchetti, Gilda Varricchi, Anna Bianco, Vasco Sequeira, Denise Hilfiker-Kleiner, Nazha Hamdani, Adelino Leite-Moreira, Manuel Mayr, Ines Falcão-Pires, Thomas Thum, Dana K Dawson, Jean-Luc Balligand, Stephane Heymans

Research output: Contribution to journalArticle

8 Citations (Scopus)
4 Downloads (Pure)

Abstract

Disturbed metabolism as a consequence of obesity and diabetes may cause cardiac diseases (recently highlighted in the CVR spotlight issue on Metabolic cardiomyopathies).1 In turn, the metabolism of the heart may also be disturbed in genetic and acquired forms of hypertrophic cardiac disease. Here, we provide an overview of recent insights on metabolic changes in genetic hypertrophic cardiomyopathy (HCM) and discuss several therapies which may be explored to target disturbed metabolism and prevent onset of cardiac hypertrophy.

Original languageEnglish
Pages (from-to)1273-1280
Number of pages8
JournalCardiovascular Research
Volume114
Issue number10
Early online date15 Jun 2018
DOIs
Publication statusPublished - 1 Aug 2018

Fingerprint

Hypertrophic Cardiomyopathy
Heart Diseases
Cardiomegaly
Cardiomyopathies
Obesity
Therapeutics

Keywords

  • Journal Article
  • hypertrophic cardiomyopathy
  • mutations
  • metabolism

Cite this

van der Velden, J., Gabriele Tocchetti, C., Varricchi, G., Bianco, A., Sequeira, V., Hilfiker-Kleiner, D., ... Heymans, S. (2018). Metabolic changes in hypertrophic cardiomyopathies: Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology. Cardiovascular Research, 114(10), 1273-1280. https://doi.org/10.1093/cvr/cvy147

Metabolic changes in hypertrophic cardiomyopathies : Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology. / van der Velden, Jolanda; Gabriele Tocchetti, Carlo; Varricchi, Gilda; Bianco, Anna; Sequeira, Vasco; Hilfiker-Kleiner, Denise; Hamdani, Nazha; Leite-Moreira, Adelino; Mayr, Manuel; Falcão-Pires, Ines; Thum, Thomas; Dawson, Dana K; Balligand, Jean-Luc; Heymans, Stephane.

In: Cardiovascular Research, Vol. 114, No. 10, 01.08.2018, p. 1273-1280.

Research output: Contribution to journalArticle

van der Velden, J, Gabriele Tocchetti, C, Varricchi, G, Bianco, A, Sequeira, V, Hilfiker-Kleiner, D, Hamdani, N, Leite-Moreira, A, Mayr, M, Falcão-Pires, I, Thum, T, Dawson, DK, Balligand, J-L & Heymans, S 2018, 'Metabolic changes in hypertrophic cardiomyopathies: Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology', Cardiovascular Research, vol. 114, no. 10, pp. 1273-1280. https://doi.org/10.1093/cvr/cvy147
van der Velden, Jolanda ; Gabriele Tocchetti, Carlo ; Varricchi, Gilda ; Bianco, Anna ; Sequeira, Vasco ; Hilfiker-Kleiner, Denise ; Hamdani, Nazha ; Leite-Moreira, Adelino ; Mayr, Manuel ; Falcão-Pires, Ines ; Thum, Thomas ; Dawson, Dana K ; Balligand, Jean-Luc ; Heymans, Stephane. / Metabolic changes in hypertrophic cardiomyopathies : Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology. In: Cardiovascular Research. 2018 ; Vol. 114, No. 10. pp. 1273-1280.
@article{3360b15c730e43c586299c51143e0fd4,
title = "Metabolic changes in hypertrophic cardiomyopathies: Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology",
abstract = "Disturbed metabolism as a consequence of obesity and diabetes may cause cardiac diseases (recently highlighted in the CVR spotlight issue on Metabolic cardiomyopathies).1 In turn, the metabolism of the heart may also be disturbed in genetic and acquired forms of hypertrophic cardiac disease. Here, we provide an overview of recent insights on metabolic changes in genetic hypertrophic cardiomyopathy (HCM) and discuss several therapies which may be explored to target disturbed metabolism and prevent onset of cardiac hypertrophy.",
keywords = "Journal Article, hypertrophic cardiomyopathy, mutations, metabolism",
author = "{van der Velden}, Jolanda and {Gabriele Tocchetti}, Carlo and Gilda Varricchi and Anna Bianco and Vasco Sequeira and Denise Hilfiker-Kleiner and Nazha Hamdani and Adelino Leite-Moreira and Manuel Mayr and Ines Falc{\~a}o-Pires and Thomas Thum and Dawson, {Dana K} and Jean-Luc Balligand and Stephane Heymans",
note = "JV is supported by the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2014-40 DOSIS. SH has received funding from the European Union Commission’s Seventh Framework programme under grant agreement N° 305507 (HOMAGE), N° 602904 (FIBROTARGETS) and FP7-Health-2013- Innovations-1 N° 602156 (HECATOS). . We acknowledge the support from the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2011-ARENA, CVON2016-Early HFPEF, and ShePREDICTS. This research is cofinanced as a PPP-allowance Research and Innovation by the Ministry of Economic Affairs within Top Sector Life sciences & Health. This research was co-funded by the C3 project “Vision Core Leuven” of the Leuven University",
year = "2018",
month = "8",
day = "1",
doi = "10.1093/cvr/cvy147",
language = "English",
volume = "114",
pages = "1273--1280",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Metabolic changes in hypertrophic cardiomyopathies

T2 - Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology

AU - van der Velden, Jolanda

AU - Gabriele Tocchetti, Carlo

AU - Varricchi, Gilda

AU - Bianco, Anna

AU - Sequeira, Vasco

AU - Hilfiker-Kleiner, Denise

AU - Hamdani, Nazha

AU - Leite-Moreira, Adelino

AU - Mayr, Manuel

AU - Falcão-Pires, Ines

AU - Thum, Thomas

AU - Dawson, Dana K

AU - Balligand, Jean-Luc

AU - Heymans, Stephane

N1 - JV is supported by the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2014-40 DOSIS. SH has received funding from the European Union Commission’s Seventh Framework programme under grant agreement N° 305507 (HOMAGE), N° 602904 (FIBROTARGETS) and FP7-Health-2013- Innovations-1 N° 602156 (HECATOS). . We acknowledge the support from the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2011-ARENA, CVON2016-Early HFPEF, and ShePREDICTS. This research is cofinanced as a PPP-allowance Research and Innovation by the Ministry of Economic Affairs within Top Sector Life sciences & Health. This research was co-funded by the C3 project “Vision Core Leuven” of the Leuven University

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Disturbed metabolism as a consequence of obesity and diabetes may cause cardiac diseases (recently highlighted in the CVR spotlight issue on Metabolic cardiomyopathies).1 In turn, the metabolism of the heart may also be disturbed in genetic and acquired forms of hypertrophic cardiac disease. Here, we provide an overview of recent insights on metabolic changes in genetic hypertrophic cardiomyopathy (HCM) and discuss several therapies which may be explored to target disturbed metabolism and prevent onset of cardiac hypertrophy.

AB - Disturbed metabolism as a consequence of obesity and diabetes may cause cardiac diseases (recently highlighted in the CVR spotlight issue on Metabolic cardiomyopathies).1 In turn, the metabolism of the heart may also be disturbed in genetic and acquired forms of hypertrophic cardiac disease. Here, we provide an overview of recent insights on metabolic changes in genetic hypertrophic cardiomyopathy (HCM) and discuss several therapies which may be explored to target disturbed metabolism and prevent onset of cardiac hypertrophy.

KW - Journal Article

KW - hypertrophic cardiomyopathy

KW - mutations

KW - metabolism

U2 - 10.1093/cvr/cvy147

DO - 10.1093/cvr/cvy147

M3 - Article

VL - 114

SP - 1273

EP - 1280

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 10

ER -